mRNA Platform Global Strategic Research Analysis 2023-2030: US Holds Leading Position, while Asia-Pacific Exhibits Lucrative Growth in mRNA Vaccines Market
July 09, 2024 06:09 ET
|
Research and Markets
Dublin, July 09, 2024 (GLOBE NEWSWIRE) -- The "mRNA Platform - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for mRNA Platform was...
Global Vaccine Delivery Devices Market Analysis & Forecast 2024-2034
May 27, 2024 04:01 ET
|
Research and Markets
Dublin, May 27, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Delivery Devices Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Global $94B+ Vaccines Market Outlook, 2024-2030 by Type, Technology, Indication, Route of Administration, Age Group and Region - Rising Need for DPT Vaccine for Protection Against Serious Respiratory Ailments
May 08, 2024 03:50 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA...
Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030, Featuring Profiles of GSK, Novavax, SPI Pharma (Associated British Foods), Agenus, and CSL Among Others
April 10, 2024 04:05 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Vaccine Adjuvants Market Size, Share & Industry Trends Analysis, 2023-2030" report has been added to ResearchAndMarkets.com's offering.The...
mRNA Platform Global Strategic Research Report 2024
April 05, 2024 09:17 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "mRNA Platform - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The report delves into the mRNA...
mRNA Vaccines in the Global Infectious Diseases Market: Opportunities, Challenges, Unmet Needs, Current Companies and Market Outlook
March 04, 2024 11:54 ET
|
Research and Markets
Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "mRNA Vaccines in Infectious Diseases Market Overview" report has been added to ResearchAndMarkets.com's offering.The report provides an assessment of...
BioNTech erreicht Meilenstein in der Errichtung einer Produktionsstätte für mRNA-basierte Impfstoffe in Ruanda
December 18, 2023 13:15 ET
|
BioNTech SE
Die Errichtung des ersten BioNTainers als Hightech-Produktionslösung für mRNA-Arzneimittel ist ein entscheidender Schritt zum Aufbau eines resilienten Impfstoff-Ökosystems in Afrika sowie in der...
BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda
December 18, 2023 13:15 ET
|
BioNTech SE
Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Africa and future pandemic preparednessBioNTech...
BioNTech weiht am 18. Dezember 2023 ersten afrikanischen Standort ein
December 12, 2023 06:45 ET
|
BioNTech SE
MAINZ, Deutschland, 12. Dezember 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Montag, den 18. Dezember 2023, den ersten afrikanischen Standort des...
BioNTech to Inaugurate First African Site on December 18, 2023
December 12, 2023 06:45 ET
|
BioNTech SE
MAINZ, Germany, December 12, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will inaugurate its first African site in Kigali, Rwanda, on Monday, December 18th, 2023....